Activation of PI3K signalling, through AKT activation, PTEN deletion, growth factor stimulation or aberrant growth factor receptor signalling, may indicate potential sensitivity of tumours to mTOR inhibition [232]. This evidence concerns the gene AKT1 and neoplasm.